Flow cytometric analysis of platelet activation under calcium ion-chelating conditions.
Platelet activation and aggregation results in factitious counting and sizing in routine haematology testing. In this study, the possibility of platelet activation in anticoagulated solutions was examined. Whole blood was examined using an automated counter and a flow cytometer before and after strong vortex agitation. Blood treated with ethylenediaminetetraacetic acid (EDTA) exhibited platelet activation both pre- and postagitation but activated platelets did not cause platelet aggregation. With sodium citrate, platelets were only minimally activated both pre- and postagitation. Heparin-treated blood exhibited minimal platelet activation preagitation, but agitation resulted in strong platelet activation and aggregation. Platelet size was increased by agitation in blood with EDTA and with sodium citrate, in association with significant increases in mean platelet volume (MPV) and platelet distribution width (PDW), but MPV and PDW were significantly higher in EDTA solution than in sodium citrate solution. Change in platelet size was observed even in the presence of EDTA, indicating that careful sampling and processing are needed in the collection of specimens. Specimens obtained from patients with EDTA-dependent pseudothrombocytopenia exhibited the same level of activation as controls, although platelets exhibited aggregation in such specimens. In conclusion, platelet activation involving platelet size change can occur in the absence of calcium ions in blood treated with EDTA.
Nishioka
T
T
Department of Clinical and Laboratory Medicine, Osaka City University Medical School, Abeno, Osaka, Japan.
Yokota
M
M
Tsuda
I
I
Tatsumi
N
N
D000925:Anticoagulants / Q000494:pharmacology; D016477:Artifacts; D002118:Calcium / Q000097:blood*; D048429:Cell Size; D002614:Chelating Agents / Q000494:pharmacology*; D002951:Citrates / Q000494:pharmacology; D003951:Diagnostic Errors; D004492:Edetic Acid / Q000494:pharmacology*; D005434:Flow Cytometry; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count; D000077559:Sodium Citrate; D013921:Thrombocytopenia / Q000097:blood / Q000175:diagnosis*
D000925:Anticoagulants; D002614:Chelating Agents; D002951:Citrates; D000077559:Sodium Citrate; D006493:Heparin; D004492:Edetic Acid; D002118:Calcium